Preparation of fluorescently-labeled amyloid-beta peptide assemblies: The effect of fluorophore conjugation on structure and function

Journal of Molecular Recognition

Volumn 22, Issue 5, 2009, Pages 403-413

  Jungbauer, L M ^a   Yu, C ^a   Laxton, K J ^a   LaDu, M J ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

AFM; Amyloid beta; Assembly; Cellular uptake; Fibril; Fluorescence; Neuro 2A cells; Oligomer

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); FLUORESCENT DYE; PEPTIDE FRAGMENT;

ANIMAL; ATOMIC FORCE MICROSCOPY; BIOLOGICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; CONFERENCE PAPER; HUMAN; METABOLISM; MOUSE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN MULTIMERIZATION; TUMOR CELL LINE; WESTERN BLOTTING;

AMYLOID BETA-PROTEIN; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLUORESCENT DYES; HUMANS; MICE; MICROSCOPY, ATOMIC FORCE; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; PEPTIDE FRAGMENTS; PROTEIN MULTIMERIZATION;

EID: 68949163262     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.948     Document Type: Conference Paper

References (48)

1. Bitan G, Fradinger EA, Spring SM, Teplow DB. 2005. Neurotoxic protein oligomers-what you see is not alwayswhat you get. Amyloid 12: 88-95.
2. Brazil MI, Chung H, Maxfield FR. 2000. Effects of incorporation of immunoglobulin G and complement component C1q on uptake and degradation of Alzheimer's disease amyloid fibrils by microglia. J. Biol. Chem. 275: 16941-16947.
3. Chafekar SM, Baas F, Scheper W. 2008. Oligomer-specific Abeta toxicity in cell models is mediated by selective uptake. Biochim. Biophys. Acta 1782: 523-531.
4. Chaney MO, Stine WB, Kokjohn TA, Kuo YM, Esh C, Rahman A, Luehrs DC, Schmidt AM, Stern D, Yan SD, Roher AE. 2005. RAGE and amyloid beta interactions: atomic force microscopy and molecular modeling. Biochim. Biophys. Acta 1741: 199-205.
5. Cheng IH, Scearce-Levie K, Legleiter J, Palop JJ, Gerstein H, Bien-Ly N, Puolivali J, Lesne S, Ashe KH, Muchowski PJ, Mucke L. 2007. Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. J. Biol. Chem. 282: 23818-23828.
6. Choucair A, Chakrapani M, Chakravarthy B, Katsaras J, Johnston LJ. 2007. Preferential accumulation of Abeta(1-42) on gel phase domains of lipid bilayers: an AFM and fluorescence study. Biochim. Biophys. Acta 1768: 146-154.
7. Chung H, Brazil MI, Soe TT, Maxfield FR. 1999. Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid betapeptide by microglial cells. J. Biol. Chem. 274: 32301-32308.
8. Clifford PM, Zarrabi S, Siu G, Kinsler KJ, Kosciuk MC, Venkataraman V, D'Andrea MR, Dinsmore S, Nagele RG. 2007. Abeta peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons. Brain Res. 1142: 223-236.
9. Dahlgren KN, Manelli AM, Stine WB Jr, Baker LK, Krafft GA, LaDu MJ. 2002. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J. Biol. Chem. 277: 32046-32053.
10. El Khoury J, Toft M, Hickman SE, Means TK, Terada K, Geula C, Luster AD. 2007. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 13: 432-438.
11. Frost D, Gorman PM, Yip CM, Chakrabartty A. 2003. Co-incorporation of A beta 40 and A beta 42 to form mixed pre-fibrillar aggregates. Eur. J. Biochem. 270: 654-663.
12. Giunta B, Zhou Y, Hou H, Rrapo E, Fernandez F, Tan J. 2008. HIV-1 TAT inhibits microglial phagocytosis of abeta peptide. Intl. J. Clin. Expmtl. Pathol. 1: 260-275.
13. Goldsbury C, Kistler J, Aebi U, Arvinte T, Cooper GJ. 1999. Watching amyloid fibrils grow by time-lapse atomic force microscopy. J. Mol. Biol. 285: 33-39.
14. Ha C, Ryu J, Park CB. 2007. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template. Biochemistry (Mosc). 46: 6118-6125.
15. Harper JD, Wong SS, Lieber CM, Lansbury PT. 1997. Observation of metastable Abeta amyloid protofibrils by atomic force microscopy. Chem. Biol. 4: 119-125.
16. Harper JD, Wong SS, Lieber CM, Lansbury PT Jr. 1999. Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease. Biochemistry (Mosc). 38: 8972-8980.
17. Hickman SE, Allison EK, El Khoury J. 2008. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J. Neurosci. 28: 8354-8360.
18. Huang TH, Yang DS, Plaskos NP, Go S, Yip CM, Fraser PE, Chakrabartty A. 2000. Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide. J. Mol. Biol. 297: 73-87.
19. Jiang Q, Lee CY, Mandrekar S, Wilkinson B, Cramer P, Zelcer N, Mann K, Lamb B, Willson TM, Collins JL, Richardson JC, Smith JD, Comery TA, Riddell D, Holtzman DM, Tontonoz P, Landreth GT. 2008. ApoE promotes the proteolytic degradation of Abeta. Neuron 58: 681-693.
20. Kowalewski T, Holtzman DM. 1999. In situ atomic force microscopy study of Alzheimer's beta-amyloid peptide on different substrates: new insights into mechanism of beta-sheet formation. Proc. Natl. Acad. Sci. U.S.A. 96: 3688-3693.
21. Kuhnke D, Jedlitschky G, Grube M, Krohn M, Jucker M, Mosyagin I, Cascorbi I, Walker LC, Kroemer HK, Warzok RW, Vogelgesang S. 2007. MDR1-P-Glycoprotein (ABCB1) mediates transport of Alzheimer's amyloid-beta peptides-implications for the mechanisms of Abeta clearance at the blood-brain barrier. Brain Pathol. 17: 347-353.
22. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch DE, Krafft GA, Klein WL. 1998. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U.S.A. 95: 6448-6453.
23. Legleiter J, Czilli DL, Gitter B, DeMattos RB, Holtzman DM, Kowalewski T. 2004. Effect of different anti-Abeta antibodies on Abeta fibrillogenesis as assessed by atomic force microscopy. J. Mol. Biol. 335: 997-1006.
24. Legleiter J, Kowalewski T. 2004. Atomic force microscopy of beta-amyloid: static and dynamic studies of nanostructure and its formation. Methods Mol. Biol. 242: 349-364.
25. Li R, Shen Y, Yang LB, Lue LF, Finch C, Rogers J. 2000. Estrogen enhances uptake of amyloid beta-protein by microglia derived from the human cortex. J. Neurochem. 75: 1447-1454.
26. Majumdar A, Chung H, Dolios G,Wang R, Asamoah N, Lobel P, Maxfield FR. 2007. Degradation of fibrillar forms of Alzheimer's amyloid betapeptide by macrophages. Neurobiol. Aging 29(5): 707-715.
27. Manelli AM, Bulfinch LC, Sullivan PM, LaDu MJ. 2007. Abeta42 neurotoxicity in primary co-cultures: effect of apoE isoform and Abeta conformation. Neurobiol. Aging 28: 1139-1147.
28. Manelli AM, Stine WB, Van Eldik LJ, LaDu MJ. 2004. ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function. J. Mol. Neurosci. 23: 235-246.
29. Mastrangelo IA, Ahmed M, Sato T, LiuW,Wang C, Hough P, Smith SO. 2006. High-resolution atomic force microscopy of soluble Abeta42 oligomers. J. Mol. Biol. 358: 106-119.
30. McAllister C, Karymov MA, Kawano Y, Lushnikov AY, Mikheikin A, Uversky VN, Lyubchenko YL. 2005. Protein interactions and misfolding analyzed by AFM force spectroscopy. J. Mol. Biol. 354: 1028-1042.
31. Nielsen HM, Veerhuis R, Holmqvist B, Janciauskiene S. 2008. Binding and uptake of Abeta1-42 by primary human astrocytes in vitro. Glia. This article is an Epub ahead of print. Published online: 5 December 2008, DOI. 10.1002/glia.20822
32. Parbhu A, Lin H, Thimm J, Lal R. 2002. Imaging real-time aggregation of amyloid beta protein (1-42) by atomic force microscopy. Peptides. 23: 1265-1270.
33. Paresce DM, Ghosh RN, Maxfield FR. 1996. Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron 17: 553-565.
34. Parvathy S, Rajadas J, Ryan H, Vaziri S, Anderson L, Murphy GM Jr. 2008. Abeta peptide conformation determines uptake and interleukin-1alpha expression by primary microglial cells. Neurobiol. Aging. This article is an Epub ahead of print. Published online: 11 Marc. 2008. DOI. 10.1016/j.neurobiolaging. 2008.01.011
35. Rahimi F, Shanmugam A, Bitan G. 2008. Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer's disease and related disorders. Curr. Alzheimer Res. 5: 319-341.
36. Roher AE, Chaney MO, Kuo YM, Webster SD, Stine WB, Haverkamp LJ, Woods AS, Cotter RJ, Tuohy JM, Krafft GA, Bonnell BS, Emmerling MR. 1996. Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J. Biol. Chem. 271: 20631-20635.
37. Saavedra L, Mohamed A, Ma V, Kar S, de Chaves EP. 2007. Internalization of beta-amyloid peptide by primary neurons in the absence of apolipoprotein E. J. Biol. Chem. 282: 35722-35732.
38. Simakova O, Arispe NJ. 2007. The cell-selective neurotoxicity of the Alzheimer's Abeta peptide is determined by surface phosphatidylserine and cytosolic ATP levels. Membrane binding is required for Abeta toxicity. J. Neurosci. 27: 13719-13729.
39. Smits HA, van Beelen AJ, de Vos NM, Rijsmus A, van der Bruggen T, Verhoef J, van Muiswinkel FL, Nottet HS. 2001. Activation of human macrophages by amyloid-beta is attenuated by astrocytes. J. Immunol. 166: 6869-6876.
40. Stine WB Jr, Dahlgren KN, Krafft GK, LaDu MJ. 2003. In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J. Biol. Chem. 278: 11612-11622.
41. Teplow DB. 2006. Preparation of amyloid beta-protein for structural and functional studies. Methods Enzymol. 413: 20-33.
42. Trommer BL, Shah C, Yun SH, Gamkrelidze G, Pasternak ES, Stine WB, Manelli A, Sullivan P, Pasternak JF, LaDu MJ. 2005. ApoE isoformspecific effects on LTP: blockade by oligomeric amyloid-beta1-42. Neurobiol. Dis. 18: 75-82.
43. Verdier Y, Zarandi M, Penke B. 2004. Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease. J Pept Sci. 10: 229-248.
44. Webster SD, Galvan MD, Ferran E, Garzon-Rodriguez W, Glabe CG, Tenner AJ. 2001. Antibody-mediated phagocytosis of the amyloid betapeptide in microglia is differentially modulated by C1q. J. Immunol. 166: 7496-7503.
45. White JA, Manelli AM, Holmberg KH, Van Eldik LJ, LaDu MJ. 2005. Differential effects of oligomeric and fibrillar amyloid-beta1-42 on astrocyte-mediated inflammation. Neurobiol. Dis. 18: 459-465.
46. Yang DS, Yip CM, Huang TH, Chakrabartty A, Fraser PE. 1999. Manipulating the amyloid-beta aggregation pathway with chemical chaperones. J. Biol. Chem. 274: 32970-32974.
47. Yankner BA, Lu T. 2008. Amyloid beta -protein toxicity and the pathogenesis of Alzheimer's disease. J. Biol. Chem. 284(8): 4755-4759.
48. Yip CM, Darabie AA, McLaurin J. 2002. Abeta42-peptide assembly on lipid bilayers. J. Mol. Biol. 318: 97-107.